Calavo's Q1 results were disappointing with significant misses on revenue and EPS estimates. The company's performance has been affected by market dynamics within its avocado business. The company's revenue has been declining over the last three years, which is among the worst in the consumer staples industry.
A GameStop GME$遊戲驛站(GME.US)$director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s KSS +5.21%$柯爾百貨(KSS.US)$and avocado slinger Calavo Growers$卡拉沃養殖(CVGW.US)$picked up millions of dollars of stock.
As the first quarter came to a close, some company insiders bought up shares on the open market. A GameStop$遊戲驛站(GME.US)$director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s$柯爾百貨(KSS.US)$and avocado slinger Calavo Growers CVGW$卡拉沃養殖(CVGW.US)$picked up millions of dollars of stock.
Gainers: •$Okta(OKTA.US)$+15.8% (In reaction to earnings) •$StoneCo(STNE.US)$+12.9% (In reaction to earnings) •$Turning Point Therapeutics(TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$Amylyx Pharmaceuticals(AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
卡拉沃養殖股票討論區
A GameStop $遊戲驛站(GME.US)$ director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s $柯爾百貨(KSS.US)$ and avocado slinger Calavo Growers CVGW $卡拉沃養殖(CVGW.US)$ picked up millions of dollars of stock.
• $Okta(OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
暫無評論